Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Total Debt (2016 - 2025)

Historic Total Debt for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $33.5 billion.

  • Novartis Ag's Total Debt rose 1330.83% to $33.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $33.5 billion, marking a year-over-year increase of 1330.83%. This contributed to the annual value of $33.5 billion for FY2025, which is 1330.83% up from last year.
  • As of Q4 2025, Novartis Ag's Total Debt stood at $33.5 billion, which was up 1330.83% from $30.1 billion recorded in Q3 2025.
  • Novartis Ag's 5-year Total Debt high stood at $35.9 billion for Q1 2021, and its period low was $23.5 billion during Q3 2023.
  • Over the past 5 years, Novartis Ag's median Total Debt value was $29.4 billion (recorded in 2022), while the average stood at $29.1 billion.
  • As far as peak fluctuations go, Novartis Ag's Total Debt crashed by 1899.62% in 2021, and later skyrocketed by 2886.17% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Total Debt stood at $29.2 billion in 2021, then decreased by 10.35% to $26.2 billion in 2022, then dropped by 5.98% to $24.6 billion in 2023, then rose by 20.26% to $29.6 billion in 2024, then grew by 13.31% to $33.5 billion in 2025.
  • Its last three reported values are $33.5 billion in Q4 2025, $30.1 billion for Q3 2025, and $30.8 billion during Q2 2025.